XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $305,000 | -23.6% | 124,184 | +26.7% | 0.00% | – |
| Q2 2021 | $399,000 | +2.8% | 97,994 | +13.8% | 0.00% | – |
| Q1 2021 | $388,000 | -63.9% | 86,092 | -60.6% | 0.00% | – |
| Q4 2020 | $1,074,000 | +131.5% | 218,244 | +178.9% | 0.00% | – |
| Q3 2020 | $464,000 | +8.7% | 78,246 | -51.3% | 0.00% | – |
| Q2 2020 | $427,000 | +80.2% | 160,532 | +32.2% | 0.00% | – |
| Q1 2020 | $237,000 | +79.5% | 121,459 | +549.5% | 0.00% | – |
| Q4 2019 | $132,000 | -55.3% | 18,700 | -37.6% | 0.00% | – |
| Q3 2019 | $295,000 | +49.7% | 29,987 | +74.2% | 0.00% | – |
| Q2 2019 | $197,000 | -53.9% | 17,213 | -59.6% | 0.00% | – |
| Q1 2019 | $427,000 | -21.1% | 42,574 | +49.4% | 0.00% | – |
| Q2 2018 | $541,000 | – | 28,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |